2026-03-24 10:07:22
Inotiv, Inc. Receives Waiver for Minimum Liquidity Covenant Under Credit Agreement
Expected Stock impact: None Expected
On March 23, 2026, Inotiv, Inc. announced that the lenders under its Credit Agreement, dated November 5, 2021, have granted a waiver of the minimum liquidity covenant for the liquidity test dates of March 20, 2026, and March 27, 2026. This waiver is limited to the specified test dates and does not amend any other provisions of the Credit Agreement. The company, which operates in the life sciences sector, has been navigating financial challenges, and this waiver may provide temporary relief as it seeks to stabilize its liquidity position. The Credit Agreement involves several subsidiaries of Inotiv, indicating a broader financial strategy that encompasses multiple facets of its operations. The waiver reflects the lenders' willingness to support Inotiv during this period, potentially allowing the company to focus on its operational execution and strategic outlook without immediate liquidity pressures. Investors and stakeholders will be closely monitoring the company's performance in the upcoming liquidity tests to assess its financial health and operational execution moving forward.
